QMCO vs. ABBV

In the year-to-date period, QMCO achieves a -78.04% return, which is significantly lower than ABBV's 6.67% return. Over the past 10 years, QMCO has underperformed ABBV with an annualized return of -28.20%, while ABBV has yielded a comparatively higher 15.93% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Quantum Corporation (QMCO) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current QMCO Sharpe Ratio is 0.15, which is lower than the ABBV Sharpe Ratio of 0.51. The chart below compares the historical Sharpe Ratios of QMCO and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

QMCO has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.43%.

The maximum QMCO drawdown since its inception was -99.93%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for QMCO and ABBV. For additional features, visit the drawdowns tool.

Quantum Corporation (QMCO) has a higher volatility of 30.51% compared to AbbVie Inc. (ABBV) at 12.85%. This indicates that QMCO's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Quantum Corporation and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.